TELA Bio, Inc. (TELA) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Tela Bio, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.494 Good afternoon, ladies and gentlemen, and welcome to the TeleBio 00:00:04.494 -- 00:00:08.856 second quarter 2026 earnings conference call. 00:00:08.856 -- 00:00:12.538 At this time, all participants are in listen-only mode. 00:00:12.538 -- 00:00:16.241 Following the prepared remarks, there'll be a question and answer session. 00:00:16.241 -- 00:00:19.522 Please be advised that today's conference is being recorded. 00:00:19.522 -- 00:00:23.864 I will now like to turn the conference over to Louisa Smith. 00:00:25.006 -- 00:00:27.603 Thank you, Lisa, and good afternoon, everyone. 00:00:27.603 -- 00:00:32.024 Earlier today, Tela Bio released financial results for the second quarter and to June 00:00:32.024 -- 00:00:37.726 30th, 2026. A copy of the press release is available on the company's website. 00:00:37.726 -- 00:00:42.907 Joining me on today's call are Joe Capper, Chairman of the Board, Heather Goetz, Chief 00:00:42.907 -- 00:00:48.208 Executive Officer, Jeff Blizzard, President, Roberto Cuca, Chief 00:00:48.208 -- 00:00:53.730 Operating Officer and Chief Financial Officer, and Jim Hagen, Senior Vice President 00:00:53.730 -- 00:00:58.667 of Strategic Operations and Marketing. Before we begin, I'd like to remind you that during 00:00:58.667 -- 00:01:02.589 this conference call, the company may make projections and forward-looking statements 00:01:02.589 -- 00:01:07.252 regarding future events. We encourage you to review the company's past and future filings 00:01:07.252 -- 00:01:12.254 with the SEC, including, without limitation, the company's quarterly reports 00:01:12.254 -- 00:01:17.597 on Forms 10Q, which identify the specific risk factors that may cause actual results 00:01:17.597 -- 00:01:22.840 or events to differ materia...